 | • レポートコード：D005-04184 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、配合経口避妊薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。配合経口避妊薬の種類別市場規模（15〜24歳、25〜34歳、35〜44歳、44歳以上）、用途別市場規模（病院、家庭、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Actavis、Noven Pharmaceuticals、Bayer、Agile Therapeutics、Ortho-McNeil-Janssen Pharmaceuticals、Allergan、Mylan、ANI Pharmaceuticals、Teva Pharmaceutical Industries、Johnson & Johnson ・地域別グローバル市場分析 2015年-2020年 ・配合経口避妊薬の北米市場（アメリカ、カナダ、メキシコ） ・配合経口避妊薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・配合経口避妊薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・配合経口避妊薬の南米市場（ブラジル、アルゼンチン） ・配合経口避妊薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：15〜24歳、25〜34歳、35〜44歳、44歳以上 ・用途別分析：病院、家庭、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Combined Hormonal Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 20710 million by 2025, from USD 18300 million in 2019.
The Combined Hormonal Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Combined Hormonal Contraceptives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Combined Hormonal Contraceptives market has been segmented into
15-24 years
25-34 years
35-44 years
Above 44 years
By Application, Combined Hormonal Contraceptives has been segmented into:
Hospitals
Household
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Combined Hormonal Contraceptives market presented in the report. This section sheds light on the sales growth of different regional and country-level Combined Hormonal Contraceptives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Combined Hormonal Contraceptives market.
The report offers in-depth assessment of the growth and other aspects of the Combined Hormonal Contraceptives market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Combined Hormonal Contraceptives Market Share Analysis
Combined Hormonal Contraceptives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Combined Hormonal Contraceptives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Combined Hormonal Contraceptives sales, revenue and market share for each player covered in this report.
The major players covered in Combined Hormonal Contraceptives are:
Actavis
Noven Pharmaceuticals
Bayer
Agile Therapeutics
Ortho-McNeil-Janssen Pharmaceuticals
Allergan
Mylan
ANI Pharmaceuticals
Teva Pharmaceutical Industries
Johnson & Johnson
Among other players domestic and global, Combined Hormonal Contraceptives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Combined Hormonal Contraceptives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Combined Hormonal Contraceptives, with price, sales, revenue and global market share of Combined Hormonal Contraceptives in 2018 and 2019.
Chapter 3, the Combined Hormonal Contraceptives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Combined Hormonal Contraceptives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Combined Hormonal Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Combined Hormonal Contraceptives sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Combined Hormonal Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Combined Hormonal Contraceptives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 15-24 years
1.2.3 25-34 years
1.2.4 35-44 years
1.2.5 Above 44 years
1.3 Market Analysis by Application
1.3.1 Overview: Global Combined Hormonal Contraceptives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Household
1.3.4 Clinics
1.4 Overview of Global Combined Hormonal Contraceptives Market
1.4.1 Global Combined Hormonal Contraceptives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Actavis
2.1.1 Actavis Details
2.1.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Actavis SWOT Analysis
2.1.4 Actavis Product and Services
2.1.5 Actavis Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Noven Pharmaceuticals
2.2.1 Noven Pharmaceuticals Details
2.2.2 Noven Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Noven Pharmaceuticals SWOT Analysis
2.2.4 Noven Pharmaceuticals Product and Services
2.2.5 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agile Therapeutics
2.4.1 Agile Therapeutics Details
2.4.2 Agile Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agile Therapeutics SWOT Analysis
2.4.4 Agile Therapeutics Product and Services
2.4.5 Agile Therapeutics Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ortho-McNeil-Janssen Pharmaceuticals
2.5.1 Ortho-McNeil-Janssen Pharmaceuticals Details
2.5.2 Ortho-McNeil-Janssen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ortho-McNeil-Janssen Pharmaceuticals SWOT Analysis
2.5.4 Ortho-McNeil-Janssen Pharmaceuticals Product and Services
2.5.5 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Allergan SWOT Analysis
2.6.4 Allergan Product and Services
2.6.5 Allergan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ANI Pharmaceuticals
2.8.1 ANI Pharmaceuticals Details
2.8.2 ANI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ANI Pharmaceuticals SWOT Analysis
2.8.4 ANI Pharmaceuticals Product and Services
2.8.5 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical Industries
2.9.1 Teva Pharmaceutical Industries Details
2.9.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Industries SWOT Analysis
2.9.4 Teva Pharmaceutical Industries Product and Services
2.9.5 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson SWOT Analysis
2.10.4 Johnson & Johnson Product and Services
2.10.5 Johnson & Johnson Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Combined Hormonal Contraceptives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Combined Hormonal Contraceptives Manufacturer Market Share in 2019
3.3.2 Top 6 Combined Hormonal Contraceptives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Combined Hormonal Contraceptives Sales, Revenue and Market Share by Regions
4.1.1 Global Combined Hormonal Contraceptives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Regions (2015-2020)
4.2 North America Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
4.3 Europe Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
4.5 South America Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Combined Hormonal Contraceptives Sales, Revenue and Market Share by Country
5.1.1 North America Combined Hormonal Contraceptives Sales and Market Share by Country (2015-2020)
5.1.2 North America Combined Hormonal Contraceptives Revenue and Market Share by Country (2015-2020)
5.2 United States Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
5.3 Canada Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
5.4 Mexico Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Combined Hormonal Contraceptives Sales, Revenue and Market Share by Country
6.1.1 Europe Combined Hormonal Contraceptives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Combined Hormonal Contraceptives Revenue and Market Share by Country (2015-2020)
6.2 Germany Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
6.3 UK Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
6.4 France Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
6.5 Russia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
6.6 Italy Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Combined Hormonal Contraceptives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Combined Hormonal Contraceptives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Combined Hormonal Contraceptives Revenue and Market Share by Regions (2015-2020)
7.2 China Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7.3 Japan Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7.4 Korea Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7.5 India Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
7.7 Australia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Combined Hormonal Contraceptives Sales, Revenue and Market Share by Country
8.1.1 South America Combined Hormonal Contraceptives Sales and Market Share by Country (2015-2020)
8.1.2 South America Combined Hormonal Contraceptives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
8.3 Argentina Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Combined Hormonal Contraceptives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Combined Hormonal Contraceptives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Combined Hormonal Contraceptives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
9.3 Turkey Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
9.4 Egypt Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
9.5 South Africa Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Combined Hormonal Contraceptives Sales and Market Share by Type (2015-2020)
10.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Type (2015-2020)
10.3 Global Combined Hormonal Contraceptives Price by Type (2015-2020)
11 Global Combined Hormonal Contraceptives Market Segment by Application
11.1 Global Combined Hormonal Contraceptives Sales Market Share by Application (2015-2020)
11.2 Global Combined Hormonal Contraceptives Revenue Market Share by Application (2015-2020)
11.3 Global Combined Hormonal Contraceptives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Combined Hormonal Contraceptives Sales, Revenue and Growth Rate (2021-2025)
12.2 Combined Hormonal Contraceptives Market Forecast by Regions (2021-2025)
12.2.1 North America Combined Hormonal Contraceptives Market Forecast (2021-2025)
12.2.2 Europe Combined Hormonal Contraceptives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Combined Hormonal Contraceptives Market Forecast (2021-2025)
12.2.4 South America Combined Hormonal Contraceptives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Combined Hormonal Contraceptives Market Forecast (2021-2025)
12.3 Combined Hormonal Contraceptives Market Forecast by Type (2021-2025)
12.3.1 Global Combined Hormonal Contraceptives Sales Forecast by Type (2021-2025)
12.3.2 Global Combined Hormonal Contraceptives Market Share Forecast by Type (2021-2025)
12.4 Combined Hormonal Contraceptives Market Forecast by Application (2021-2025)
12.4.1 Global Combined Hormonal Contraceptives Sales Forecast by Application (2021-2025)
12.4.2 Global Combined Hormonal Contraceptives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Combined Hormonal Contraceptives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Combined Hormonal Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Combined Hormonal Contraceptives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Actavis Basic Information, Manufacturing Base and Competitors
Table 8. Actavis Combined Hormonal Contraceptives Major Business
Table 9. Actavis Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 10. Actavis SWOT Analysis
Table 11. Actavis Combined Hormonal Contraceptives Product and Services
Table 12. Actavis Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Noven Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Noven Pharmaceuticals Combined Hormonal Contraceptives Major Business
Table 15. Noven Pharmaceuticals Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 16. Noven Pharmaceuticals SWOT Analysis
Table 17. Noven Pharmaceuticals Combined Hormonal Contraceptives Product and Services
Table 18. Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Combined Hormonal Contraceptives Major Business
Table 21. Bayer Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Combined Hormonal Contraceptives Product and Services
Table 24. Bayer Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Agile Therapeutics Basic Information, Manufacturing Base and Competitors
Table 26. Agile Therapeutics Combined Hormonal Contraceptives Major Business
Table 27. Agile Therapeutics Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 28. Agile Therapeutics SWOT Analysis
Table 29. Agile Therapeutics Combined Hormonal Contraceptives Product and Services
Table 30. Agile Therapeutics Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ortho-McNeil-Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Major Business
Table 33. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 34. Ortho-McNeil-Janssen Pharmaceuticals SWOT Analysis
Table 35. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product and Services
Table 36. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Allergan Basic Information, Manufacturing Base and Competitors
Table 38. Allergan Combined Hormonal Contraceptives Major Business
Table 39. Allergan Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 40. Allergan SWOT Analysis
Table 41. Allergan Combined Hormonal Contraceptives Product and Services
Table 42. Allergan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Combined Hormonal Contraceptives Major Business
Table 45. Mylan Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 46. Mylan SWOT Analysis
Table 47. Mylan Combined Hormonal Contraceptives Product and Services
Table 48. Mylan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. ANI Pharmaceuticals Combined Hormonal Contraceptives Major Business
Table 51. ANI Pharmaceuticals Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 52. ANI Pharmaceuticals SWOT Analysis
Table 53. ANI Pharmaceuticals Combined Hormonal Contraceptives Product and Services
Table 54. ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 56. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Major Business
Table 57. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 58. Teva Pharmaceutical Industries SWOT Analysis
Table 59. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product and Services
Table 60. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Combined Hormonal Contraceptives Major Business
Table 63. Johnson & Johnson Combined Hormonal Contraceptives Total Revenue (USD Million) (2017-2018)
Table 64. Johnson & Johnson SWOT Analysis
Table 65. Johnson & Johnson Combined Hormonal Contraceptives Product and Services
Table 66. Johnson & Johnson Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Combined Hormonal Contraceptives Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Combined Hormonal Contraceptives Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Combined Hormonal Contraceptives Sales by Regions (2015-2020) (K MT)
Table 70. Global Combined Hormonal Contraceptives Sales Market Share by Regions (2015-2020)
Table 71. Global Combined Hormonal Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Combined Hormonal Contraceptives Sales by Countries (2015-2020) (K MT)
Table 73. North America Combined Hormonal Contraceptives Sales Market Share by Countries (2015-2020)
Table 74. North America Combined Hormonal Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020)
Table 76. Europe Combined Hormonal Contraceptives Sales by Countries (2015-2020) (K MT)
Table 77. Europe Combined Hormonal Contraceptives Sales Market Share by Countries (2015-2020)
Table 78. Europe Combined Hormonal Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Combined Hormonal Contraceptives Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Combined Hormonal Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Combined Hormonal Contraceptives Sales by Countries (2015-2020) (K MT)
Table 83. South America Combined Hormonal Contraceptives Sales Market Share by Countries (2015-2020)
Table 84. South America Combined Hormonal Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Combined Hormonal Contraceptives Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Combined Hormonal Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020)
Table 90. Global Combined Hormonal Contraceptives Sales by Type (2015-2020) (K MT)
Table 91. Global Combined Hormonal Contraceptives Sales Share by Type (2015-2020)
Table 92. Global Combined Hormonal Contraceptives Revenue by Type (2015-2020) (USD Million)
Table 93. Global Combined Hormonal Contraceptives Revenue Share by Type (2015-2020)
Table 94. Global Combined Hormonal Contraceptives Sales by Application (2015-2020) (K MT)
Table 95. Global Combined Hormonal Contraceptives Sales Share by Application (2015-2020)
Table 96. Global Combined Hormonal Contraceptives Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Combined Hormonal Contraceptives Market Share Forecast by Regions (2021-2025)
Table 98. Global Combined Hormonal Contraceptives Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Combined Hormonal Contraceptives Market Share Forecast by Type (2021-2025)
Table 100. Global Combined Hormonal Contraceptives Sales Forecast by Application (2021-2025)
Table 101. Global Combined Hormonal Contraceptives Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Combined Hormonal Contraceptives Picture
Figure 2. Global Sales Market Share of Combined Hormonal Contraceptives by Type in 2019
Figure 3. 15-24 years Picture
Figure 4. 25-34 years Picture
Figure 5. 35-44 years Picture
Figure 6. Above 44 years Picture
Figure 7. Combined Hormonal Contraceptives Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Household Picture
Figure 10. Clinics Picture
Figure 11. Global Combined Hormonal Contraceptives Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Combined Hormonal Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Combined Hormonal Contraceptives Sales Market Share by Manufacturer in 2019
Figure 32. Global Combined Hormonal Contraceptives Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Combined Hormonal Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Combined Hormonal Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Combined Hormonal Contraceptives Revenue Market Share by Regions (2015-2020)
Figure 39. Global Combined Hormonal Contraceptives Revenue Market Share by Regions in 2018
Figure 40. North America Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
Figure 41. Europe Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
Figure 43. South America Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020)
Figure 45. North America Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Combined Hormonal Contraceptives Sales Market Share by Countries (2015-2020)
Figure 47. North America Combined Hormonal Contraceptives Sales Market Share by Countries in 2018
Figure 48. North America Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Combined Hormonal Contraceptives Revenue Market Share by Countries in 2018
Figure 50. United States Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Combined Hormonal Contraceptives Revenue Market Share by Countries in 2019
Figure 56. Germany Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Combined Hormonal Contraceptives Revenue Market Share by Regions 2019
Figure 64. China Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Combined Hormonal Contraceptives Sales Market Share by Countries in 2019
Figure 71. South America Combined Hormonal Contraceptives Revenue Market Share by Countries in 2019
Figure 72. Brazil Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Combined Hormonal Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Combined Hormonal Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Combined Hormonal Contraceptives Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Combined Hormonal Contraceptives Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Combined Hormonal Contraceptives Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Combined Hormonal Contraceptives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Combined Hormonal Contraceptives Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Combined Hormonal Contraceptives Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Combined Hormonal Contraceptives Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Combined Hormonal Contraceptives Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Combined Hormonal Contraceptives Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
避妊薬＆器具の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Contraceptives Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 24150 million by 2025, from USD 18110 million in 2019. The Contr…- 導電性武器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Conducted Electrical Weapons market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Conducted Electr…
- 人工喉頭の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Artificial Larynx market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Artificial Larynx market re…
- 人工弁の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Artificial Valve market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Artificial Valve market repo…
- セフェタメットピボキシル錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cefetamet Pivoxil Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cefetamet Pivoxil T…